Leading epidemiologists have warned that continued disruption to foreign aid funding, namely the sudden pause to the US President’s Emergency Plan for AIDS Relief (PEPFAR), could see a rise in the number of people who are resistant to HIV drugs.
PEPFAR provides a huge proportion of the funding for health systems in low middle-income countries, management of HIV.
